[PAR] QoQ Quarter Result on 31-Dec-2018 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2018
Financial Year
2019
Quarter
31-Dec-2018 [#Q2]
Profit Trend
QoQ- -68.13%
YoY- -23.15%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 CAGR
Revenue -826 826 2,956 28 2,660 22 1,766 -
PBT -7,195 -5,104 -11,227 -4,400 -2,617 -3,573 -1,457 70.20%
Tax -826 826 2,956 0 0 0 0 -
NP -7,195 -5,104 -11,227 -4,400 -2,617 -3,573 -1,457 70.20%
Tax Rate - - - - - - - -
Total Cost 6,369 5,930 14,183 4,428 5,277 3,596 3,223 25.46%
Ratio Analysis
30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 CAGR
NP Margin 871.10 -617.95 -379.84 -15,637.06 -98.38 -15,998.41 -82.52 -
Per Share
30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 CAGR
EPS -0.03 -0.03 -0.08 -0.03 -0.02 -0.03 -0.01 44.17%
EPS Diluted -0.03 -0.03 -0.08 -0.03 -0.02 -0.03 -0.01 44.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.